Hematological Oncology's 2026 Journal Metrics Score is 0.6, ranking Q4 in Pathology and Forensic Medicine and 3 other subfields. Two-year citation average from OpenAlex data, updated August 2026.
Bookmark this page — track observed submission-to-acceptance timing, FWCI and field-normalized citation data for this journal in one view.
Journal Metrics Score 2026 · 2021–2024 window citedness 1.05.
Middle 50%: 64–151 days
86 of 100 PubMed-indexed articles · 86% coverage · 2024–2025
Journal-level estimate only. Verify current charges, taxes, waivers, discounts, and article-type fees with the journal.
Paste your title to see which of this journal's published topics it overlaps with. Your title stays in your browser for this preview and is not sent anywhere.
Want ranked journals with fit reasons, risks and a submission strategy instead? See a sample AI report.
Each spoke is a 0–100 percentile within a comparable journal cohort—not a percentage grade or a single black-box rating.
58 of 1,640 works · same type, year & subfield
2 works · same type, year & subfield
Below field-year expectation
of 1,427 topic-associated OpenAlex sources by lifetime output
FWCI compares papers with the same publication year, type, and field. 1.0 is the world average; above 1.0 is above expectation. This journal's median is 0.13, so its typical recent paper runs about 87% below its field benchmark.
3.5% of recent papers rank in the global top 10% after field normalization. This is easier to compare across specialties than raw citation totals.
Volume is separated from citation accumulation so newer papers are not presented as weaker simply because they are newer.
OpenAlex source records · 2016–2025
1,640 OpenAlex works · 2021–2024
OpenAlex topics show research communities; MeSH keeps the medical taxonomy recognizable.
Select a MeSH signal to see how much Hematological Oncology publishes on it, from PubMed counts for the last five complete years.
Candidates share at least one OpenAlex subfield (or field, if too few do) with this journal's main research topics, ignoring generic catch-all topics, and are ordered by topic overlap, then current Journal Metrics Score.
* Cost is indicative only. APCs, taxes, waivers, and member discounts can change—always verify on the journal's official website.
| Category | Quartile |
|---|---|
| Pathology and Forensic Medicine | Q4 |
| Genetics | Q4 |
| Oncology | Q4 |
| Neurology | Q4 |
A lower-cited Q4 journal by citation data
By citation data, Hematological Oncology is in the lowest quartile in Pathology and Forensic Medicine and 3 other subfields and ranks #799 of 897 Oncology journals by Journal Metrics Score (top 90%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Hematological Oncology's 2026 Journal Metrics Score is 0.6. Recent papers took a median of 92 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $4,220 USD. OpenAlex classifies its papers in subfields including Pathology and Forensic Medicine, Genetics, and Oncology, so check that your topic fits its scope.
Verdict from citation data only: quartile and field rank by Journal Metrics Score (OpenAlex), publisher-reported acceptance rates, and PubMed submission and acceptance dates. See how we rank journals and how to verify indexing.
Confirm the exact title and ISSNs against the publisher homepage before a high-stakes submission decision.
Source: the current OpenAlex source record. OpenAlex works can include multiple work types. Fully Open Access is a source-level flag. Recent OA Works is summed from OpenAlex's counts_by_year series (up to the latest ten years); it is not a lifetime OA percentage. Any APC shown here is an indicative OpenAlex value—verify current charges on the journal's official website.
OpenAlex classifies Hematological Oncology's papers in subfields including Pathology and Forensic Medicine, Genetics, and Oncology. Read the aims and scope page and a few recent papers close to your topic before you prepare the manuscript.
Article types, word and figure limits, reference style, and the required statements (data availability, ethics, conflicts of interest, author contributions) are set by the journal. Prepare the cover letter and files to match them.
Hematological Oncology homepage ↗Use the submit link in Hematological Oncology's author guidelines; Wiley runs the submission site. Every author usually needs an ORCID iD, and the corresponding author needs an account on the submission site.
OpenAlex lists an indicative article processing charge of $4,220 USD. Check the current fee, waivers, and any institutional agreement on the journal website.
Recent accepted papers took a median of 92 days from submission to acceptance, including revisions (PubMed dates). Hematological Oncology does not publish an acceptance rate.
New on PubMed
Type a topic to see the newest PubMed papers from the past week and the big picture of what they found, summarized by Claude on the Pro plan. Get a free weekly email to keep up.
See a demo:GLP-1CRISPRLong COVID
Reviewer Two · coming soon
An AI pre-submission report on your manuscript: the objections a tough reviewer is likely to raise, desk-rejection risks, and better-fit journals from our data. $29 per report.
See what the report coversBy citation data, Hematological Oncology is in the lowest quartile in Pathology and Forensic Medicine and 3 other subfields and ranks #799 of 897 Oncology journals by Journal Metrics Score (top 90%). A Q4 placement means its papers are cited less than most in the subfield; on its own it does not mean the journal is predatory or that its peer review is weak. Hematological Oncology's 2026 Journal Metrics Score is 0.6. Recent papers took a median of 92 days from submission to acceptance, according to PubMed dates. OpenAlex lists an indicative article processing charge of $4,220 USD. OpenAlex classifies its papers in subfields including Pathology and Forensic Medicine, Genetics, and Oncology, so check that your topic fits its scope.
Hematological Oncology's 2026 Journal Metrics Score is 0.6, from the August 2026 data release. The score is a two-year citation average computed from OpenAlex (CC0) data: citations received in the most recent complete year to works published in the two prior years, divided by the number of those works.
We have not found an official acceptance rate published by Hematological Oncology or its publisher, and Journal Metrics does not estimate one because submission counts are not public. What recent PubMed records do show is speed: accepted papers took a median of 92 days from submission to acceptance. To judge selectivity, compare Hematological Oncology's quartile and score with similar journals, or ask the editorial office.
Hematological Oncology's best quartile is Q4. By OpenAlex subfield: Q4 in Pathology and Forensic Medicine; Q4 in Genetics; Q4 in Oncology; Q4 in Neurology. Quartiles rank journals by Journal Metrics Score within each subfield.
No. Journal Metrics computes the score independently from OpenAlex open data. Other providers use different citation databases, document types, and counting rules, so their published figures for Hematological Oncology will not match this score exactly. Compare journals using one source at a time.
Across 86 recent PubMed records with both dates, Hematological Oncology took a median of 92 days from submission to acceptance; the middle half took 64–151 days. This interval includes editorial handling and revisions, so it is not the time to a first decision.
OpenAlex lists an indicative article processing charge of $4,220 USD for Hematological Oncology. This journal-level estimate may exclude taxes, waivers, discounts, or article-type fees, so confirm the current charge on the journal's website.
Comparable journals include Journal of Clinical and Experimental Hematopathology, Seminars in Hematology, Leukemia & Lymphoma, and Blood and Lymphatic Cancer-Targets and Therapy. Compare their scores, acceptance times, and costs in the recommended alternatives on this page before choosing where to submit.
Submit online through the link in Hematological Oncology's author guidelines on the journal homepage. Before submitting, check the scope, follow the author guidelines for article type, length, and required statements, and prepare a cover letter. Accepted papers took a median of 92 days from submission to acceptance in recent PubMed records.